AEON Biopharma, Inc. (AEON) Form S-1/A — Jul 9, 2026
AEON Biopharma filed Amendment No. 1 to its Form S-1 registration statement, a pre-effective amendment submitted solely to update the calculation of the filing fee. The amendment adjusts the registration fee to reflect a proposed maximum aggregate offering price of $16.5 million for the Class A common stock underlying the Five-Year Milestone Warrants, set at 115% of the assumed public offering price.
Key figures
- Five Year Warrant Value
- $16,531,250
- Incremental Registration Fee
- $297.78
Price after filing
1 day: -3.9%7 days: -40.8%30 days: -44.9%
Close on the filing date to close N calendar days later (from $0.50). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.